Labtech

Labtech offers products and services in diagnostics, as well as biomedical research and laboratory equipment. Our 18 subsidiaries continually strive to find new solutions and the most recent technology in their respective niches.

Labtech’s offering focuses primarily on healthcare and research-laboratories. Products include instruments and equipment, combined with reagents to diagnose diseases or conduct research. Public procurement accounts for about 85 percent of sales, where the goal is to deliver the latest solutions to maximise user benefit. About 10 percent of the products are our own brands, while 90 percent involve products from leading manufacturers distributed in the Nordic region.

Freedom as a distributor allows us to respond quickly and early to find the products on the cutting edge of development

Peter Simonsbacka, Business Area Manager Labtech

Labtech net sales per country 2017

Net sales: SEK 1,393 million
EBITA: SEK 151 million
Subsidiaries: 18
Employees: 357
Percentage of net sales: 60%
 

Labtech - a business area with good prospects

The business climate for Labtech was favourable and organic growth was 7 percent, which was higher than the market in general. Acquired growth totalled 7 percent. The trend for diagnostics companies was favourable and we are further strengthening our positions within our traditional areas such as blood gas analysis and coagulation. Demand for our products in the future fields of molecular biology and microbiology increased sharply. Demand for Labtech’s advanced research reagents, instruments and microscopes also strengthened. In the last quarter we started a diagnostics company in the Baltic region. 

Since a substantial portion of Labtech’s operations are subject to public procurement, we are dependent on politicians and their decisions regarding how health care should be funded and organised. While we see both risks and opportunities, our assessment is that our subsidiaries are well-equipped to meet future demands. They are ready to meet the fast-paced challenges of innovation in digitisation and other new technology, as well as to find the right talented employees. With its competitive products, commited employees, and solid customer and supplier relationships, Labtech expects continued good growth over the comming years.

Labtech´s Product Segment

  • Hematology
  • Pathology
  • POC
  • Cellular biology
  • Analytical instruments
  • Consumables
  • Advanced instruments
  • Microbiology
  • Molecular biology
  • Clinical chemistry
  • Immunology

We speak the same language as our customers

Kai Rantanen, CEO Triolab Finland

The laboratory industry is highly innovation-intensive. New products are constantly being developed and the trend is moving increasingly towards point-of-care solutions. Labtech’s product portfolio is currently an excellent fit for many customers. But our challenge is to find tomorrow's products for the customers of the future. We have to think the same way that our customers do – and have employees with extensive knowledge of the industry and a high-level scientific perspective. Building long-term  relationships where the customer clearly benefits from meeting you is a key factor for our success.

 

Subsidiaries

Sales of laboratory equipment and service to research, industry, colleges and universities

Geographical market: Sweden

Segment: Analytical instruments and equipment as well as microscopy

Customer examples: Astra Zeneca, Lund University, Karolinska Institute

Amount of employees: 30

Sales of analytical instruments and services for surface science research and development in academia and industry

Geographical market: World Wide

Segment: Advanced material development in academia and industry

Customer examples: P&G, IBM, Apple, BASF, Stanford University, Harvard University, Peking University

Amount of employees: 60

BioNordika Group consists of: BioNordika Sweden AB, BioNordika Denmark A/S, BioNordika Finland OY, BioNordika Norway AS. Sales of laboratory equipment and reagents mainly for research

Geographical market: Sweden, Denmark, Norway, Finland, Estonia

Segment: Cell & Molecular Biology, immunology for academic research and pharma industry, as well as laboratory equipment

Customer examples: AstraZeneca, Karolinska Institute, Novo Nordisk, Novozymes, Institute for Molecular Medicine Finland

Amount of employees: 36

Sales of laboratory equipment and service to research, industry and universities

Geographical market: Denmark

Segment: Wide range of basic products and analysis instruments for laboratories

Customer examples: Novo Nordisk, Novozymes, LeoPharma, University of Copenhagen

Amount of employees: 49

Sales of diagnostic instruments and reagents to customers in the public healthcare setting and academic research

Geographical market: Finland, Sweden, Norway, Denmark, Estonia

Segment: Molecular diagnostics, microbiology, pathology, genetics, cell biology, laboratory microscopes and surgical microscopes

Customer examples: HUSLAB, The Hospital District of Helsinki and Uusimaa, Oulu University Hospital

Amount of employees: 32

Production and sales of equipment for microbiological analyses to laboratories within the food industry

Geographical market: Mainly Europe and Northern America

Segment: Food microbiology

Customer examples: Eurofins, Synlab

Amount of employees: 10

Triolab Group consists of: Triolab AB (Sweden), Triolab A/S (Denmark), Triolab OY (Finland), Triolab Baltic Oü (Estonia, Lithuania and Lativa), Bergman Diagnostika AS (Norway). Sales of diagnostic instruments and reagents

Geographical market: Sweden, Denmark, Norway, Finland, Estonia, Lithuania, Latvia

Segment: Blood gas, clinical chemistry, microbiology, molecular biology, immunology, pathology, hematology, POC and veterinary for customers in public sector and private sector medical care, as well as the pharmaceutical industry.

Customer examples: Karolinska University Hospital, Sahlgrenska Hospital, Odense University Hospital, Novo Nordisk, HUSLAB, Helsinki and Uusimaa Hospital District, Norwegian Health Care, Rikshospitalet, Haukeland University Hospital, St. Olavs Hospital

Amount of employees: 137